Prenetics Global Limited PRE
8.80 USD -1.51 (-14.65%)
Regular-session close
9.14 +0.34 +3.86%
After hours · Nov 20, 7:01 PM ET
8.70 Day range 10.29
8.80 52-week range 26.25
- YTD
- -44.13%
- 1 year
- -31.68%
News
benzinga.com B. Riley Securities Maintains Buy on Prenetics Global, Lowers Price Target to $31 B. Riley Securities analyst Jeff Van Sinderen maintains Prenetics Global (NASDAQ:PRE) with a Buy and lowers the price target from $37 to $31.
defenseworld.net Prenetics (NASDAQ: PRE) raises 2026 revenue guidance and signs Diplo as a shareholder What happened Prenetics Global Limited (NASDAQ: PRE) signed Diplo as an IM8 Global Ambassador and a Prenetics shareholder and raised 2026 revenue guidance to $220 million to $230 million. The Nov. 16…
seekingalpha.com Prenetics Global Limited (PRE) Q3 2026 Earnings Call Transcript Prenetics Global Limited (PRE) Q3 2026 Earnings Call Transcript
marketbeat.com What Prenetics Global (PRE) Said on Its Q3 Earnings Call Prenetics Global NASDAQ: PRE reported third-quarter revenue of $64.1 million as sales of its IM8 supplement brand climbed, but widened its expected second-half adjusted EBITDA loss as it plans to…
benzinga.com Crude Oil Down Over 4%; Target Earnings Top Views U.S. stocks mostly fell, led by a 1.32% Dow drop. Target beat estimates and raised guidance; TJX and Bellring rallied, while oil and metals slid.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Akanda (NASDAQ:AKAN) shares rose 66.8% to $3.42 during Wednesday's regular session. The market value of their outstanding shares is at $5.4 million. Cue Biopharma (NASDAQ:CUE) shares rose…
benzinga.com Dow Falls Over 300 Points; Nvidia Posts Upbeat Earnings U.S. stocks fell as the Dow slid 300+ points; Nvidia beat Q3 estimates, while energy, commodities and European markets declined.benzinga.com Prenetics Global Q3 EPS $(1.43) Misses $(0.72) Estimate, Sales $64.112M Beat $63.188M Estimate Prenetics Global (NASDAQ:PRE) reported quarterly losses of $(1.43) per share which missed the analyst consensus estimate of $(0.72) by 98.61 percent. This is a 248.78 percent decrease over losses of…
benzinga.com Prenetics Global Affirms FY2026 Sales Guidance of $220.000M-$230.000M vs $224.204M Est Prenetics Global (NASDAQ:PRE) affirms FY2026 sales outlook from $220.000 million-$230.000 million to $220.000 million-$230.000 million vs $224.204 million estimate.
globenewswire.com Prenetics' IM8 Reports Q3 2026 Revenue Growth of 266% YoY; Earliest Customers Have Returned More Than 3x Their Acquisition Cost in Under Two Years; Reaffirms FY 2026 Total Revenue Guidance of $220–230 Million and FY 2027 IM8 Revenue Guidance of $400 Million+ — Total revenue of $64.1 million, up ~228% YoY (~3.3x); above the Company's guidance of $63–64 million — IM8 revenue of $62.9 million, up ~266% YoY (~3.7x); above the Company's guidance of $61.5–62.5…
globenewswire.com Prenetics' IM8 Announces Three-Time GRAMMY-Winning DJ and Producer Diplo as IM8 Global Ambassador and Shareholder in Multi-Year Partnership — Diplo is IM8's first Global Ambassador from music and takes a roster built in elite sport onto the world's biggest stages — Diplo brings a social following of more than 12 million across Instagram,…benzinga.com Prenetics Global Collaborates With Authentic Brands Group To Build Care Bears By IM8 Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading consumer health company and parent of the AI-native direct-to-consumer wellness brand IM8, co-founded by David Beckham,
benzinga.com Prenetics Global Appoints Brian J. Rosin CFO, Effective Dec. 31, Succeeding Stephen Lo Prenetics Global Limited (Nasdaq: PRE) ("Prenetics" or the "Company"), the parent company of IM8, the premium health and longevity brand co-founded with David Beckham, today announced that Brian J.…
benzinga.com Maxim Group Initiates Coverage On Prenetics Global with Buy Rating, Announces Price Target of $41 Maxim Group analyst Thomas Forte initiates coverage on Prenetics Global (NASDAQ:PRE) with a Buy rating and announces Price Target of $41.
